Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.73 -0.37 (-0.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Total Current Liabilities (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International's Total Current Liabilities came in at $171.25 million for Q2 2026, up 45.3% from $117.83 million a year earlier and up 9.3% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Kiniksa Pharmaceuticals International's Total Current Liabilities was $139.18 million, up 38.3% from FY2024.

  • Total Current Liabilities has increased in each of the last six years, with a five-year compound annual growth rate of 34.3% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $100.62 million in FY2024 (+58.0%), $63.67 million in FY2023 (+35.3%), $47.07 million in FY2022 (+5.0%) and $44.82 million in FY2021 (+40.8%).
  • The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2017.
  • Year-over-year, Total Current Liabilities has increased for 11 consecutive quarters, with growth averaging 50.3% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q3 2024 (growth of 79.5%), and the weakest in Q1 2023 (a decline of 27.3%).
  • Business Quant data shows KNSA's Total Current Liabilities at $156.61 million (Q1 2026), $139.18 million (Q4 2025) and $123.59 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Kiniksa Pharmaceuticals International 11.87 Bn 10.61 Bn 220.03 Mn 171.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171.25 Mn
Mar 31, 2026 156.61 Mn
Dec 31, 2025 139.18 Mn
Sep 30, 2025 123.59 Mn
Jun 30, 2025 117.83 Mn
Mar 31, 2025 97.27 Mn
Dec 31, 2024 100.62 Mn
Sep 30, 2024 95.96 Mn
Jun 30, 2024 84.29 Mn
Mar 31, 2024 64.21 Mn
Dec 31, 2023 63.67 Mn
Sep 30, 2023 53.47 Mn
Jun 30, 2023 47.47 Mn
Mar 31, 2023 36.59 Mn
Dec 31, 2022 47.07 Mn
Sep 30, 2022 56.49 Mn
Jun 30, 2022 43.54 Mn
Mar 31, 2022 50.35 Mn
Dec 31, 2021 44.82 Mn
Sep 30, 2021 34.43 Mn
API Access

Kiniksa Pharmaceuticals International Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KNSA&period=max&api_key=YOUR_API_KEY